John Fratamico - Leidos Holdings President
LDOS Stock | USD 123.76 0.60 0.48% |
President
Dr. John J. Fratamico has served as Executive Vice President and Chief Technology Officer since November 2016 and before that, as President, National Security Solutions Surveillance and Reconnaissance Group. Before joining Leidos, Dr. Fratamico served as Chief Scientist at McDonnell Douglas Technologies Incorporated. since 2016.
Age | 59 |
Tenure | 8 years |
Professional Marks | Ph.D |
Address | 1750 Presidents Street, Reston, VA, United States, 20190 |
Phone | 571 526 6000 |
Web | https://www.leidos.com |
Leidos Holdings Management Efficiency
The company has return on total asset (ROA) of 0.0632 % which means that it generated a profit of $0.0632 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.0483 %, meaning that it created $0.0483 on every $100 dollars invested by stockholders. Leidos Holdings' management efficiency ratios could be used to measure how well Leidos Holdings manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Leidos Holdings' Return On Capital Employed is comparatively stable compared to the past year. Return On Assets is likely to gain to 0.06 in 2024, whereas Return On Tangible Assets are likely to drop 0.08 in 2024. At this time, Leidos Holdings' Other Current Assets are comparatively stable compared to the past year. Deferred Long Term Asset Charges is likely to gain to about 19.4 M in 2024, whereas Non Current Assets Total are likely to drop slightly above 5 B in 2024.Similar Executives
Showing other executives | PRESIDENT Age | ||
Anthony Maddaluna | Pfizer Inc | 62 | |
Adalberto Cantu | Home Federal Bancorp | 74 | |
Glen Brown | Home Federal Bancorp | 60 | |
Angela Hwang | Pfizer Inc | 58 | |
Douglas Lankler | Pfizer Inc | 58 | |
Kirsten LundJurgensen | Pfizer Inc | 57 | |
Nick Leschly | 2Seventy Bio | 51 | |
Kathrin Jansen | Pfizer Inc | 53 | |
Dawn Rogers | Pfizer Inc | 54 | |
Sally Susman | Pfizer Inc | 59 | |
Lidia Fonseca | Pfizer Inc | 55 | |
Joseph Wolk | Johnson Johnson | 54 | |
Michael Sneed | Johnson Johnson | 60 | |
Kathryn Wengel | Johnson Johnson | 55 | |
James Swanson | Johnson Johnson | 58 | |
Frank DAmelio | Pfizer Inc | 66 | |
Rady Johnson | Pfizer Inc | 62 | |
Geno Germano | Pfizer Inc | 53 | |
Laurie Olson | Pfizer Inc | 53 | |
James Barlow | Home Federal Bancorp | 56 | |
Mary Jones | Home Federal Bancorp | 71 |
Management Performance
Return On Equity | 0.0483 | |||
Return On Asset | 0.0632 |
Leidos Holdings Leadership Team
Elected by the shareholders, the Leidos Holdings' board of directors comprises two types of representatives: Leidos Holdings inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Leidos. The board's role is to monitor Leidos Holdings' management team and ensure that shareholders' interests are well served. Leidos Holdings' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Leidos Holdings' outside directors are responsible for providing unbiased perspectives on the board's policies.
Lawrence Nussdorf, Lead Independent Director | ||
Roger Krone, Chairman, CEO, Member of Classified Bus. Oversight Committee and Member of Ethics and Corporate Responsibility Committee | ||
Susan Stalnecker, Independent Director | ||
Mary Craft, President National Security Solutions - Global Services Group | ||
Stephen Cook, President Group | ||
Stuart Davis, Senior Relations | ||
Surya Mohapatra, Independent Director | ||
Paul Engola, Chief Human Resource Officer, Executive Vice President, Head of Business Partnerships | ||
Noel Williams, Independent Director | ||
Kelly Hernandez, Vice President of Investor Relations | ||
Randy Phillips, Sr Devel | ||
Mary Schmanske, Senior Vice President and Presidentident - Intelligence Group | ||
Gary May, Independent Director | ||
Vincent Maffeo, Executive VP and General Counsel | ||
Ranjit Chadha, Chief Accounting Officer, Corporate Controller | ||
Vice Lewis, Senior Maritime | ||
Srini Iyer, Chief Group | ||
James Carlini, Chief Officer | ||
Patrick Shanahan, Independent Director | ||
James Moos, Group President - Civil Group | ||
Roy Stevens, President - Intelligence Group | ||
John Jumper, Chairman of the Board and Presidentident, CEO | ||
Peter Berl, Senior President | ||
Maureen Waterston, Chief Human Resource Officer | ||
Miriam John, Independent Director | ||
Frank Kendall, Independent Director | ||
Gerald Fasano, Executive Vice President, President - Defense Group | ||
Steve Cook, Group President - Dynetics | ||
David King, Group President - Dynetics | ||
Elizabeth Porter, Group President - Health Group | ||
Simon Fovargue, Chief Europe | ||
Amy Smith, Senior Affairs | ||
Gerard Fasano, Executive Officer | ||
Christopher Cage, Senior Vice President, Chief Accounting Officer, Corporate Controller | ||
Melissa Koskovich, SVP Marketing | ||
John Fratamico, President National Security Solutions - Surveillance and Reconnaissance Group | ||
Ann Addison, Chief Human Resource Officer, Executive Vice President | ||
Angela Heise, President Civil Group | ||
Thomas Bell, CEO Director | ||
Jerald Howe, Executive Vice President General Counsel | ||
Gregory Dahlberg, Independent Director | ||
Jonathan Scholl, President Health and Infrastructure group | ||
Harry Kraemer, Independent Director | ||
Sarah Allen, Chief HR Officer and Executive VP | ||
Kevin Massengill, Senior Vice President - International Strategic Account Executive | ||
Jason Albanese, Senior Development | ||
Robert Shapard, Lead Independent Director | ||
Timothy Reardon, President Defense & Intelligence Group | ||
Kimberly Rupert, Senior Officer | ||
Rick Reynolds, Senior Group | ||
David Fubini, Independent Director | ||
Michael Leiter, Executive Vice President - Business Development & Strategy | ||
Valerie Baldwin, Senior Vice President of Government Affairs | ||
Daniel IV, Chief SVP | ||
Carly Kimball, Senior Vice President Chief Accounting Officer, Corporate Controller | ||
Terry Phillips, Senior Vice President Chief Security Officer | ||
Robert Kovarik, Independent Director | ||
James Reagan, Chief Financial Officer, Executive Vice President | ||
John Hamre, Independent Director |
Leidos Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Leidos Holdings a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity | 0.0483 | |||
Return On Asset | 0.0632 | |||
Profit Margin | 0.01 % | |||
Operating Margin | 0.09 % | |||
Current Valuation | 21.54 B | |||
Shares Outstanding | 135.03 M | |||
Shares Owned By Insiders | 1.00 % | |||
Shares Owned By Institutions | 78.20 % | |||
Number Of Shares Shorted | 1.33 M | |||
Price To Earning | 22.14 X |
Leidos Holdings Investors Sentiment
The influence of Leidos Holdings' investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Leidos. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to Leidos Holdings' public news can be used to forecast risks associated with an investment in Leidos. The trend in average sentiment can be used to explain how an investor holding Leidos can time the market purely based on public headlines and social activities around Leidos Holdings. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Leidos Holdings' market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Leidos Holdings' and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Leidos Holdings' news discussions. The higher the estimated score, the more favorable is the investor's outlook on Leidos Holdings.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Leidos Holdings in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Leidos Holdings' short interest history, or implied volatility extrapolated from Leidos Holdings options trading.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Leidos Holdings. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in persons. For more information on how to buy Leidos Stock please use our How to Invest in Leidos Holdings guide.You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.
Complementary Tools for Leidos Stock analysis
When running Leidos Holdings' price analysis, check to measure Leidos Holdings' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Leidos Holdings is operating at the current time. Most of Leidos Holdings' value examination focuses on studying past and present price action to predict the probability of Leidos Holdings' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Leidos Holdings' price. Additionally, you may evaluate how the addition of Leidos Holdings to your portfolios can decrease your overall portfolio volatility.
Transaction History View history of all your transactions and understand their impact on performance | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Commodity Directory Find actively traded commodities issued by global exchanges |
Is Leidos Holdings' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Leidos Holdings. If investors know Leidos will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Leidos Holdings listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.296 | Dividend Share 1.46 | Earnings Share 1.45 | Revenue Per Share 112.686 | Quarterly Revenue Growth 0.077 |
The market value of Leidos Holdings is measured differently than its book value, which is the value of Leidos that is recorded on the company's balance sheet. Investors also form their own opinion of Leidos Holdings' value that differs from its market value or its book value, called intrinsic value, which is Leidos Holdings' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Leidos Holdings' market value can be influenced by many factors that don't directly affect Leidos Holdings' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Leidos Holdings' value and its price as these two are different measures arrived at by different means. Investors typically determine if Leidos Holdings is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Leidos Holdings' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.